世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

毛瘡治療の世界市場成長(現状と展望)2024-2030年


Global Pediculosis Treatment Market Growth (Status and Outlook) 2024-2030

LPI(LPインフォメーション)の最新調査によると、世界の毛包虫症治療剤の市場規模は2023年に100万米ドルと評価されました。下流市場での需要の増加に伴い、ペディキュラ症治療薬はレビュー期間中に年平均成長率... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション
2024年6月21日 US$3,660
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
114 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

LPI(LPインフォメーション)の最新調査によると、世界の毛包虫症治療剤の市場規模は2023年に100万米ドルと評価されました。下流市場での需要の増加に伴い、ペディキュラ症治療薬はレビュー期間中に年平均成長率(CAGR)%で2030年までに百万米ドルの再調整規模になると予測されています。
この調査レポートは、世界の毛包虫症治療市場の成長可能性を明らかにしています。毛包虫症治療は今後の市場において安定した成長を示すと予想される。しかし、製品の差別化、コストの削減、サプライチェーンの最適化は、引き続き毛包虫症治療薬の普及に不可欠です。市場プレーヤーは、研究開発に投資し、戦略的パートナーシップを構築し、進化する消費者の嗜好に合わせた製品を提供することで、毛包虫症治療薬市場が提供する膨大な機会を活用する必要があります。
ペディキュラ症は、血液を吸うフシギダネや外部寄生性昆虫であるシラミの侵入によって誘発される。
世界の医薬品市場は2022年に1475億ドルで、今後6年間は年平均成長率5%で成長する。医薬品市場には化学医薬品と生物学的製剤がある。生物製剤は2022年に3810億ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間&政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要とする患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19の大流行はワクチン開発とサプライチェーン管理の重要性を浮き彫りにし、製薬企業が公衆衛生の新たなニーズに機敏に対応する必要性をさらに強調している。
主な特徴
毛包虫症治療薬市場に関する本レポートは、様々な側面を反映し、業界に関する貴重な洞察を提供します。
市場規模と成長:この調査レポートは、毛包虫症治療薬市場の現在の規模と成長の概要を提供します。過去のデータ、タイプ別(例えば、頭部ペディキュラ症、陰部ペディキュラ症)の市場区分、地域別内訳を含む場合があります。
市場促進要因と課題:政府規制、環境問題、技術の進歩、消費者の嗜好の変化など、毛包虫症治療市場の成長を促進する要因を特定・分析することができます。また、インフラストラクチャーの制限、射程距離への不安、高額な初期費用など、業界が直面する課題も明らかにすることができる。
競合情勢:この調査レポートは、毛包虫症治療市場内の競合状況の分析を提供します。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれます。また、新興プレーヤーとその潜在的な市場への影響もハイライトできます。
技術開発:この調査レポートは、毛包虫症治療産業における最新の技術開発を掘り下げることができます。これには、毛包虫症治療技術の進歩、毛包虫症治療の新規参入、毛包虫症治療の新規投資、毛包虫症治療の将来を形作るその他の技術革新が含まれます。
川下における需要者の好み:本レポートは、毛包虫症治療薬市場における顧客の購買行動と採用傾向に光を当てることができます。顧客の購買決定、毛包虫症治療製品の嗜好に影響を与える要因も含まれます。
政府の政策とインセンティブ:この調査レポートは、政府の政策やインセンティブが毛包虫症治療薬市場に与える影響を分析しています。これには、規制の枠組み、補助金、税制上の優遇措置、その他ペディキュラ症治療薬市場の促進を目的とした施策の評価が含まれます。また、市場成長促進におけるこれらの政策の有効性も評価します。
環境への影響と持続可能性この調査レポートは、毛包虫症治療市場の環境への影響と持続可能性の側面を評価します。
市場予測と将来展望:調査レポートでは、実施した分析に基づいて、乾癬治療産業の市場予測と展望を提供しています。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれます。
提言と機会本レポートは、業界関係者、政策立案者、投資家への提言で締めくくられています。市場関係者が新たなトレンドを活用し、課題を克服し、毛包虫症治療薬市場の成長と発展に貢献するための潜在的な機会を強調しています。
市場細分化:
毛包虫症治療薬市場はタイプ別と用途別に分類されます。2019年から2030年までの期間について、セグメント間の成長により、タイプ別、アプリケーション別の消費額の正確な計算と予測を提供します。
タイプ別
シラミタイプ別
アタマジラミ症
陰部毛ジラミ症
体部毛ジラミ症
治療別
ジメチコンローション
イソプロピルアルコール
窒息性ペディキュライザー
ペトロラタム
酸化水銀軟膏
その他
用途別セグメント
病院
診療所
在宅医療
その他
本レポートは地域別にも市場を分割しています:
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
アメリカン・バンガード・コーポレーション(タイラテック社)
テック・ラボラトリーズ・インク
アーバー・ファーマシューティカルズLLC
ロジック・プロダクト・グループ
ハーバード・ドラッグ・グループ(メジャー・ファーマシューティカルズ)
パラプロ・エルエルシー
プレステージ・コンシューマー・ヘルスケア社
バイエル
STADA Arzneimittel AG(ソーントン&ロス)
ラヴィファーム


ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pediculosis Treatment Market Size 2019-2030
2.1.2 Pediculosis Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Pediculosis Treatment Segment by Type
2.2.1 Pediculosis Capitis
2.2.2 Pediculosis Pubis
2.2.3 Pediculosis Corporis
2.3 Pediculosis Treatment Market Size by Type
2.3.1 Pediculosis Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Pediculosis Treatment Market Size Market Share by Type (2019-2024)
2.4 Pediculosis Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Home Care
2.4.4 Others
2.5 Pediculosis Treatment Market Size by Application
2.5.1 Pediculosis Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Pediculosis Treatment Market Size Market Share by Application (2019-2024)
3 Pediculosis Treatment Market Size by Player
3.1 Pediculosis Treatment Market Size Market Share by Players
3.1.1 Global Pediculosis Treatment Revenue by Players (2019-2024)
3.1.2 Global Pediculosis Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Pediculosis Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pediculosis Treatment by Regions
4.1 Pediculosis Treatment Market Size by Regions (2019-2024)
4.2 Americas Pediculosis Treatment Market Size Growth (2019-2024)
4.3 APAC Pediculosis Treatment Market Size Growth (2019-2024)
4.4 Europe Pediculosis Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Pediculosis Treatment Market Size Growth (2019-2024)
5 Americas
5.1 Americas Pediculosis Treatment Market Size by Country (2019-2024)
5.2 Americas Pediculosis Treatment Market Size by Type (2019-2024)
5.3 Americas Pediculosis Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pediculosis Treatment Market Size by Region (2019-2024)
6.2 APAC Pediculosis Treatment Market Size by Type (2019-2024)
6.3 APAC Pediculosis Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pediculosis Treatment by Country (2019-2024)
7.2 Europe Pediculosis Treatment Market Size by Type (2019-2024)
7.3 Europe Pediculosis Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pediculosis Treatment by Region (2019-2024)
8.2 Middle East & Africa Pediculosis Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Pediculosis Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Pediculosis Treatment Market Forecast
10.1 Global Pediculosis Treatment Forecast by Regions (2025-2030)
10.1.1 Global Pediculosis Treatment Forecast by Regions (2025-2030)
10.1.2 Americas Pediculosis Treatment Forecast
10.1.3 APAC Pediculosis Treatment Forecast
10.1.4 Europe Pediculosis Treatment Forecast
10.1.5 Middle East & Africa Pediculosis Treatment Forecast
10.2 Americas Pediculosis Treatment Forecast by Country (2025-2030)
10.2.1 United States Pediculosis Treatment Market Forecast
10.2.2 Canada Pediculosis Treatment Market Forecast
10.2.3 Mexico Pediculosis Treatment Market Forecast
10.2.4 Brazil Pediculosis Treatment Market Forecast
10.3 APAC Pediculosis Treatment Forecast by Region (2025-2030)
10.3.1 China Pediculosis Treatment Market Forecast
10.3.2 Japan Pediculosis Treatment Market Forecast
10.3.3 Korea Pediculosis Treatment Market Forecast
10.3.4 Southeast Asia Pediculosis Treatment Market Forecast
10.3.5 India Pediculosis Treatment Market Forecast
10.3.6 Australia Pediculosis Treatment Market Forecast
10.4 Europe Pediculosis Treatment Forecast by Country (2025-2030)
10.4.1 Germany Pediculosis Treatment Market Forecast
10.4.2 France Pediculosis Treatment Market Forecast
10.4.3 UK Pediculosis Treatment Market Forecast
10.4.4 Italy Pediculosis Treatment Market Forecast
10.4.5 Russia Pediculosis Treatment Market Forecast
10.5 Middle East & Africa Pediculosis Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Pediculosis Treatment Market Forecast
10.5.2 South Africa Pediculosis Treatment Market Forecast
10.5.3 Israel Pediculosis Treatment Market Forecast
10.5.4 Turkey Pediculosis Treatment Market Forecast
10.5.5 GCC Countries Pediculosis Treatment Market Forecast
10.6 Global Pediculosis Treatment Forecast by Type (2025-2030)
10.7 Global Pediculosis Treatment Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 American Vanguard Corporation(TyraTech, Inc.)
11.1.1 American Vanguard Corporation(TyraTech, Inc.) Company Information
11.1.2 American Vanguard Corporation(TyraTech, Inc.) Pediculosis Treatment Product Offered
11.1.3 American Vanguard Corporation(TyraTech, Inc.) Pediculosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 American Vanguard Corporation(TyraTech, Inc.) Main Business Overview
11.1.5 American Vanguard Corporation(TyraTech, Inc.) Latest Developments
11.2 Tec Laboratories Inc.
11.2.1 Tec Laboratories Inc. Company Information
11.2.2 Tec Laboratories Inc. Pediculosis Treatment Product Offered
11.2.3 Tec Laboratories Inc. Pediculosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Tec Laboratories Inc. Main Business Overview
11.2.5 Tec Laboratories Inc. Latest Developments
11.3 Arbor Pharmaceuticals LLC
11.3.1 Arbor Pharmaceuticals LLC Company Information
11.3.2 Arbor Pharmaceuticals LLC Pediculosis Treatment Product Offered
11.3.3 Arbor Pharmaceuticals LLC Pediculosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Arbor Pharmaceuticals LLC Main Business Overview
11.3.5 Arbor Pharmaceuticals LLC Latest Developments
11.4 Logic Product Group
11.4.1 Logic Product Group Company Information
11.4.2 Logic Product Group Pediculosis Treatment Product Offered
11.4.3 Logic Product Group Pediculosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Logic Product Group Main Business Overview
11.4.5 Logic Product Group Latest Developments
11.5 The Harvard Drug Group(Major Pharmaceuticals)
11.5.1 The Harvard Drug Group(Major Pharmaceuticals) Company Information
11.5.2 The Harvard Drug Group(Major Pharmaceuticals) Pediculosis Treatment Product Offered
11.5.3 The Harvard Drug Group(Major Pharmaceuticals) Pediculosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 The Harvard Drug Group(Major Pharmaceuticals) Main Business Overview
11.5.5 The Harvard Drug Group(Major Pharmaceuticals) Latest Developments
11.6 ParaPRO, LLC
11.6.1 ParaPRO, LLC Company Information
11.6.2 ParaPRO, LLC Pediculosis Treatment Product Offered
11.6.3 ParaPRO, LLC Pediculosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 ParaPRO, LLC Main Business Overview
11.6.5 ParaPRO, LLC Latest Developments
11.7 Prestige Consumer Healthcare, Inc.
11.7.1 Prestige Consumer Healthcare, Inc. Company Information
11.7.2 Prestige Consumer Healthcare, Inc. Pediculosis Treatment Product Offered
11.7.3 Prestige Consumer Healthcare, Inc. Pediculosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Prestige Consumer Healthcare, Inc. Main Business Overview
11.7.5 Prestige Consumer Healthcare, Inc. Latest Developments
11.8 Bayer AG
11.8.1 Bayer AG Company Information
11.8.2 Bayer AG Pediculosis Treatment Product Offered
11.8.3 Bayer AG Pediculosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Bayer AG Main Business Overview
11.8.5 Bayer AG Latest Developments
11.9 STADA Arzneimittel AG(Thornton & Ross)
11.9.1 STADA Arzneimittel AG(Thornton & Ross) Company Information
11.9.2 STADA Arzneimittel AG(Thornton & Ross) Pediculosis Treatment Product Offered
11.9.3 STADA Arzneimittel AG(Thornton & Ross) Pediculosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 STADA Arzneimittel AG(Thornton & Ross) Main Business Overview
11.9.5 STADA Arzneimittel AG(Thornton & Ross) Latest Developments
11.10 Lavipharm
11.10.1 Lavipharm Company Information
11.10.2 Lavipharm Pediculosis Treatment Product Offered
11.10.3 Lavipharm Pediculosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Lavipharm Main Business Overview
11.10.5 Lavipharm Latest Developments
12 Research Findings and Conclusion

 

ページTOPに戻る


 

Summary

According to our LPI (LP Information) latest study, the global Pediculosis Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Pediculosis Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Pediculosis Treatment market. Pediculosis Treatment are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Pediculosis Treatment. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Pediculosis Treatment market.
Pediculosis is induced by infestation of blood feeding Phthiraptera as well as an ectoparasitic insect Louse.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Pediculosis Treatment market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Pediculosis Treatment market. It may include historical data, market segmentation by Type (e.g., Pediculosis Capitis, Pediculosis Pubis), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Pediculosis Treatment market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Pediculosis Treatment market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Pediculosis Treatment industry. This include advancements in Pediculosis Treatment technology, Pediculosis Treatment new entrants, Pediculosis Treatment new investment, and other innovations that are shaping the future of Pediculosis Treatment.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Pediculosis Treatment market. It includes factors influencing customer ' purchasing decisions, preferences for Pediculosis Treatment product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Pediculosis Treatment market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Pediculosis Treatment market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Pediculosis Treatment market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Pediculosis Treatment industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Pediculosis Treatment market.
Market Segmentation:
Pediculosis Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
by Louse Type
Pediculosis Capitis
Pediculosis Pubis
Pediculosis Corporis
by Treatment
Dimeticone Lotion
Isopropyl Alcohol
Suffocation-Based Pediculicide
Petrolatum
Mercuric Oxide Ointment
Others
Segmentation by application
Hospitals
Clinics
Home Care
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
American Vanguard Corporation(TyraTech, Inc.)
Tec Laboratories Inc.
Arbor Pharmaceuticals LLC
Logic Product Group
The Harvard Drug Group(Major Pharmaceuticals)
ParaPRO, LLC
Prestige Consumer Healthcare, Inc.
Bayer AG
STADA Arzneimittel AG(Thornton & Ross)
Lavipharm



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pediculosis Treatment Market Size 2019-2030
2.1.2 Pediculosis Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Pediculosis Treatment Segment by Type
2.2.1 Pediculosis Capitis
2.2.2 Pediculosis Pubis
2.2.3 Pediculosis Corporis
2.3 Pediculosis Treatment Market Size by Type
2.3.1 Pediculosis Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Pediculosis Treatment Market Size Market Share by Type (2019-2024)
2.4 Pediculosis Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Home Care
2.4.4 Others
2.5 Pediculosis Treatment Market Size by Application
2.5.1 Pediculosis Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Pediculosis Treatment Market Size Market Share by Application (2019-2024)
3 Pediculosis Treatment Market Size by Player
3.1 Pediculosis Treatment Market Size Market Share by Players
3.1.1 Global Pediculosis Treatment Revenue by Players (2019-2024)
3.1.2 Global Pediculosis Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Pediculosis Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pediculosis Treatment by Regions
4.1 Pediculosis Treatment Market Size by Regions (2019-2024)
4.2 Americas Pediculosis Treatment Market Size Growth (2019-2024)
4.3 APAC Pediculosis Treatment Market Size Growth (2019-2024)
4.4 Europe Pediculosis Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Pediculosis Treatment Market Size Growth (2019-2024)
5 Americas
5.1 Americas Pediculosis Treatment Market Size by Country (2019-2024)
5.2 Americas Pediculosis Treatment Market Size by Type (2019-2024)
5.3 Americas Pediculosis Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pediculosis Treatment Market Size by Region (2019-2024)
6.2 APAC Pediculosis Treatment Market Size by Type (2019-2024)
6.3 APAC Pediculosis Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pediculosis Treatment by Country (2019-2024)
7.2 Europe Pediculosis Treatment Market Size by Type (2019-2024)
7.3 Europe Pediculosis Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pediculosis Treatment by Region (2019-2024)
8.2 Middle East & Africa Pediculosis Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Pediculosis Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Pediculosis Treatment Market Forecast
10.1 Global Pediculosis Treatment Forecast by Regions (2025-2030)
10.1.1 Global Pediculosis Treatment Forecast by Regions (2025-2030)
10.1.2 Americas Pediculosis Treatment Forecast
10.1.3 APAC Pediculosis Treatment Forecast
10.1.4 Europe Pediculosis Treatment Forecast
10.1.5 Middle East & Africa Pediculosis Treatment Forecast
10.2 Americas Pediculosis Treatment Forecast by Country (2025-2030)
10.2.1 United States Pediculosis Treatment Market Forecast
10.2.2 Canada Pediculosis Treatment Market Forecast
10.2.3 Mexico Pediculosis Treatment Market Forecast
10.2.4 Brazil Pediculosis Treatment Market Forecast
10.3 APAC Pediculosis Treatment Forecast by Region (2025-2030)
10.3.1 China Pediculosis Treatment Market Forecast
10.3.2 Japan Pediculosis Treatment Market Forecast
10.3.3 Korea Pediculosis Treatment Market Forecast
10.3.4 Southeast Asia Pediculosis Treatment Market Forecast
10.3.5 India Pediculosis Treatment Market Forecast
10.3.6 Australia Pediculosis Treatment Market Forecast
10.4 Europe Pediculosis Treatment Forecast by Country (2025-2030)
10.4.1 Germany Pediculosis Treatment Market Forecast
10.4.2 France Pediculosis Treatment Market Forecast
10.4.3 UK Pediculosis Treatment Market Forecast
10.4.4 Italy Pediculosis Treatment Market Forecast
10.4.5 Russia Pediculosis Treatment Market Forecast
10.5 Middle East & Africa Pediculosis Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Pediculosis Treatment Market Forecast
10.5.2 South Africa Pediculosis Treatment Market Forecast
10.5.3 Israel Pediculosis Treatment Market Forecast
10.5.4 Turkey Pediculosis Treatment Market Forecast
10.5.5 GCC Countries Pediculosis Treatment Market Forecast
10.6 Global Pediculosis Treatment Forecast by Type (2025-2030)
10.7 Global Pediculosis Treatment Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 American Vanguard Corporation(TyraTech, Inc.)
11.1.1 American Vanguard Corporation(TyraTech, Inc.) Company Information
11.1.2 American Vanguard Corporation(TyraTech, Inc.) Pediculosis Treatment Product Offered
11.1.3 American Vanguard Corporation(TyraTech, Inc.) Pediculosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 American Vanguard Corporation(TyraTech, Inc.) Main Business Overview
11.1.5 American Vanguard Corporation(TyraTech, Inc.) Latest Developments
11.2 Tec Laboratories Inc.
11.2.1 Tec Laboratories Inc. Company Information
11.2.2 Tec Laboratories Inc. Pediculosis Treatment Product Offered
11.2.3 Tec Laboratories Inc. Pediculosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Tec Laboratories Inc. Main Business Overview
11.2.5 Tec Laboratories Inc. Latest Developments
11.3 Arbor Pharmaceuticals LLC
11.3.1 Arbor Pharmaceuticals LLC Company Information
11.3.2 Arbor Pharmaceuticals LLC Pediculosis Treatment Product Offered
11.3.3 Arbor Pharmaceuticals LLC Pediculosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Arbor Pharmaceuticals LLC Main Business Overview
11.3.5 Arbor Pharmaceuticals LLC Latest Developments
11.4 Logic Product Group
11.4.1 Logic Product Group Company Information
11.4.2 Logic Product Group Pediculosis Treatment Product Offered
11.4.3 Logic Product Group Pediculosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Logic Product Group Main Business Overview
11.4.5 Logic Product Group Latest Developments
11.5 The Harvard Drug Group(Major Pharmaceuticals)
11.5.1 The Harvard Drug Group(Major Pharmaceuticals) Company Information
11.5.2 The Harvard Drug Group(Major Pharmaceuticals) Pediculosis Treatment Product Offered
11.5.3 The Harvard Drug Group(Major Pharmaceuticals) Pediculosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 The Harvard Drug Group(Major Pharmaceuticals) Main Business Overview
11.5.5 The Harvard Drug Group(Major Pharmaceuticals) Latest Developments
11.6 ParaPRO, LLC
11.6.1 ParaPRO, LLC Company Information
11.6.2 ParaPRO, LLC Pediculosis Treatment Product Offered
11.6.3 ParaPRO, LLC Pediculosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 ParaPRO, LLC Main Business Overview
11.6.5 ParaPRO, LLC Latest Developments
11.7 Prestige Consumer Healthcare, Inc.
11.7.1 Prestige Consumer Healthcare, Inc. Company Information
11.7.2 Prestige Consumer Healthcare, Inc. Pediculosis Treatment Product Offered
11.7.3 Prestige Consumer Healthcare, Inc. Pediculosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Prestige Consumer Healthcare, Inc. Main Business Overview
11.7.5 Prestige Consumer Healthcare, Inc. Latest Developments
11.8 Bayer AG
11.8.1 Bayer AG Company Information
11.8.2 Bayer AG Pediculosis Treatment Product Offered
11.8.3 Bayer AG Pediculosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Bayer AG Main Business Overview
11.8.5 Bayer AG Latest Developments
11.9 STADA Arzneimittel AG(Thornton & Ross)
11.9.1 STADA Arzneimittel AG(Thornton & Ross) Company Information
11.9.2 STADA Arzneimittel AG(Thornton & Ross) Pediculosis Treatment Product Offered
11.9.3 STADA Arzneimittel AG(Thornton & Ross) Pediculosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 STADA Arzneimittel AG(Thornton & Ross) Main Business Overview
11.9.5 STADA Arzneimittel AG(Thornton & Ross) Latest Developments
11.10 Lavipharm
11.10.1 Lavipharm Company Information
11.10.2 Lavipharm Pediculosis Treatment Product Offered
11.10.3 Lavipharm Pediculosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Lavipharm Main Business Overview
11.10.5 Lavipharm Latest Developments
12 Research Findings and Conclusion

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21 10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る